News
The complex relationship between obesity and certain EDs, under the spotlight
The need for a comprehensive study of obesity and EDs is becoming increasingly apparent.
Against misinformation, VacunAcció
The scientific and artistic high school students from Institut Bellvitge have created awareness campaigns about vaccination within the framework of the 4th edition of VacunAcció.
IDIBELL promotes physical activity on World Health Day
Although a sedentary lifestyle is one of the main risk factors for many diseases, 47% of the Spanish population never engage in physical activity.
Breast cancer patients highly satisfied with micropigmentation and nipple and areola reconstruction, study finds
Patients undergoing reconstructive breast surgery show a high degree of satisfaction with micropigmentation and surgical reconstruction of the areola and nipple, according to a study led by the GRIN – IDIBELL and HUB nursing research group.
IDIBELL and BST generate a bank of stem cells that can be used as precursors for cell therapy
Scientists have generated seven pluripotent stem cell lines compatible with 20% of the Spanish population
New step in understanding the influence of genes on cancer risk
Certain variations in our DNA, which had previously gone unnoticed, can have a significant impact on the development of cancer.
A new edition of the NeuroBell Retreat is held
IDIBELL held a new edition of the NeuroBell Retreat, an event to strengthen the relationship between neuroscience research groups. Throughout the day, short presentations were made by all the research groups and also more extensive scientific talks.
Women with resistant OCD have a worse answer to deep-brain stimulation
The IDIBELL and Bellvitge University Hospital Psychiatry and Mental Health research group has published an article that indicates that men have a better long-term prognosis in treatment with deep brain stimulation (DBS) for Obsessive Compulsive Disorder (OCD).
IDIBELL celebrates a new edition of the Accelerator Meeting Point
In this event, innovative projects from the biotech and biomedical sector looking for market transfer resources will be presented.